Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A comprehensive overview on the surgical management of secondary lymphedema of the upper and lower extremities related to prior oncologic therapies.

Identifieur interne : 000118 ( PubMed/Corpus ); précédent : 000117; suivant : 000119

A comprehensive overview on the surgical management of secondary lymphedema of the upper and lower extremities related to prior oncologic therapies.

Auteurs : Ramon Garza ; Roman Skoracki ; Karen Hock ; Stephen P. Povoski

Source :

RBID : pubmed:28679373

Abstract

Secondary lymphedema of the upper and lower extremities related to prior oncologic therapies, including cancer surgeries, radiation therapy, and chemotherapy, is a major cause of long-term morbidity in cancer patients. For the upper extremities, it is most commonly associated with prior oncologic therapies for breast cancer, while for the lower extremities, it is most commonly associated with oncologic therapies for gynecologic cancers, urologic cancers, melanoma, and lymphoma. Both non-surgical and surgical management strategies have been developed and utilized, with the primary goal of all management strategies being volume reduction of the affected extremity, improvement in patient symptomology, and the reduction/elimination of resultant extremity-related morbidities, including recurrent infections. Surgical management strategies include: (i) ablative surgical methods (i.e., Charles procedure, suction-assisted lipectomy/liposuction) and (ii) physiologic surgical methods (i.e., lymphaticolymphatic bypass, lymphaticovenular anastomosis, vascularized lymph node transfer, vascularized omental flap transfer). While these surgical management strategies can result in dramatic improvement in extremity-related symptomology and improve quality of life for these cancer patients, many formidable challenges remain for successful management of secondary lymphedema. It is hopeful that ongoing clinical research efforts will ultimately lead to more complete and sustainable treatment strategies and perhaps a cure for secondary lymphedema and its devastating resultant morbidities.

DOI: 10.1186/s12885-017-3444-9
PubMed: 28679373

Links to Exploration step

pubmed:28679373

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">A comprehensive overview on the surgical management of secondary lymphedema of the upper and lower extremities related to prior oncologic therapies.</title>
<author>
<name sortKey="Garza, Ramon" sort="Garza, Ramon" uniqKey="Garza R" first="Ramon" last="Garza">Ramon Garza</name>
<affiliation>
<nlm:affiliation>PRMA Plastic Surgery, San Antonio, TX, 78240, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Skoracki, Roman" sort="Skoracki, Roman" uniqKey="Skoracki R" first="Roman" last="Skoracki">Roman Skoracki</name>
<affiliation>
<nlm:affiliation>Department of Plastic Surgery, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA. roman.skoracki@osumc.edu.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hock, Karen" sort="Hock, Karen" uniqKey="Hock K" first="Karen" last="Hock">Karen Hock</name>
<affiliation>
<nlm:affiliation>Division of Oncology Rehabilitation Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Povoski, Stephen P" sort="Povoski, Stephen P" uniqKey="Povoski S" first="Stephen P" last="Povoski">Stephen P. Povoski</name>
<affiliation>
<nlm:affiliation>Division of Surgical Oncology, Department of Surgery, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA. stephen.povoski@osumc.edu.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28679373</idno>
<idno type="pmid">28679373</idno>
<idno type="doi">10.1186/s12885-017-3444-9</idno>
<idno type="wicri:Area/PubMed/Corpus">000118</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000118</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">A comprehensive overview on the surgical management of secondary lymphedema of the upper and lower extremities related to prior oncologic therapies.</title>
<author>
<name sortKey="Garza, Ramon" sort="Garza, Ramon" uniqKey="Garza R" first="Ramon" last="Garza">Ramon Garza</name>
<affiliation>
<nlm:affiliation>PRMA Plastic Surgery, San Antonio, TX, 78240, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Skoracki, Roman" sort="Skoracki, Roman" uniqKey="Skoracki R" first="Roman" last="Skoracki">Roman Skoracki</name>
<affiliation>
<nlm:affiliation>Department of Plastic Surgery, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA. roman.skoracki@osumc.edu.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hock, Karen" sort="Hock, Karen" uniqKey="Hock K" first="Karen" last="Hock">Karen Hock</name>
<affiliation>
<nlm:affiliation>Division of Oncology Rehabilitation Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Povoski, Stephen P" sort="Povoski, Stephen P" uniqKey="Povoski S" first="Stephen P" last="Povoski">Stephen P. Povoski</name>
<affiliation>
<nlm:affiliation>Division of Surgical Oncology, Department of Surgery, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA. stephen.povoski@osumc.edu.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">BMC cancer</title>
<idno type="eISSN">1471-2407</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Secondary lymphedema of the upper and lower extremities related to prior oncologic therapies, including cancer surgeries, radiation therapy, and chemotherapy, is a major cause of long-term morbidity in cancer patients. For the upper extremities, it is most commonly associated with prior oncologic therapies for breast cancer, while for the lower extremities, it is most commonly associated with oncologic therapies for gynecologic cancers, urologic cancers, melanoma, and lymphoma. Both non-surgical and surgical management strategies have been developed and utilized, with the primary goal of all management strategies being volume reduction of the affected extremity, improvement in patient symptomology, and the reduction/elimination of resultant extremity-related morbidities, including recurrent infections. Surgical management strategies include: (i) ablative surgical methods (i.e., Charles procedure, suction-assisted lipectomy/liposuction) and (ii) physiologic surgical methods (i.e., lymphaticolymphatic bypass, lymphaticovenular anastomosis, vascularized lymph node transfer, vascularized omental flap transfer). While these surgical management strategies can result in dramatic improvement in extremity-related symptomology and improve quality of life for these cancer patients, many formidable challenges remain for successful management of secondary lymphedema. It is hopeful that ongoing clinical research efforts will ultimately lead to more complete and sustainable treatment strategies and perhaps a cure for secondary lymphedema and its devastating resultant morbidities.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="In-Process" Owner="NLM">
<PMID Version="1">28679373</PMID>
<DateCreated>
<Year>2017</Year>
<Month>07</Month>
<Day>06</Day>
</DateCreated>
<DateRevised>
<Year>2017</Year>
<Month>07</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1471-2407</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>17</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2017</Year>
<Month>Jul</Month>
<Day>05</Day>
</PubDate>
</JournalIssue>
<Title>BMC cancer</Title>
<ISOAbbreviation>BMC Cancer</ISOAbbreviation>
</Journal>
<ArticleTitle>A comprehensive overview on the surgical management of secondary lymphedema of the upper and lower extremities related to prior oncologic therapies.</ArticleTitle>
<Pagination>
<MedlinePgn>468</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s12885-017-3444-9</ELocationID>
<Abstract>
<AbstractText>Secondary lymphedema of the upper and lower extremities related to prior oncologic therapies, including cancer surgeries, radiation therapy, and chemotherapy, is a major cause of long-term morbidity in cancer patients. For the upper extremities, it is most commonly associated with prior oncologic therapies for breast cancer, while for the lower extremities, it is most commonly associated with oncologic therapies for gynecologic cancers, urologic cancers, melanoma, and lymphoma. Both non-surgical and surgical management strategies have been developed and utilized, with the primary goal of all management strategies being volume reduction of the affected extremity, improvement in patient symptomology, and the reduction/elimination of resultant extremity-related morbidities, including recurrent infections. Surgical management strategies include: (i) ablative surgical methods (i.e., Charles procedure, suction-assisted lipectomy/liposuction) and (ii) physiologic surgical methods (i.e., lymphaticolymphatic bypass, lymphaticovenular anastomosis, vascularized lymph node transfer, vascularized omental flap transfer). While these surgical management strategies can result in dramatic improvement in extremity-related symptomology and improve quality of life for these cancer patients, many formidable challenges remain for successful management of secondary lymphedema. It is hopeful that ongoing clinical research efforts will ultimately lead to more complete and sustainable treatment strategies and perhaps a cure for secondary lymphedema and its devastating resultant morbidities.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Garza</LastName>
<ForeName>Ramon</ForeName>
<Initials>R</Initials>
<Suffix>3rd</Suffix>
<AffiliationInfo>
<Affiliation>PRMA Plastic Surgery, San Antonio, TX, 78240, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Skoracki</LastName>
<ForeName>Roman</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Plastic Surgery, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA. roman.skoracki@osumc.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hock</LastName>
<ForeName>Karen</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Oncology Rehabilitation Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Povoski</LastName>
<ForeName>Stephen P</ForeName>
<Initials>SP</Initials>
<AffiliationInfo>
<Affiliation>Division of Surgical Oncology, Department of Surgery, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA. stephen.povoski@osumc.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2017</Year>
<Month>07</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>BMC Cancer</MedlineTA>
<NlmUniqueID>100967800</NlmUniqueID>
<ISSNLinking>1471-2407</ISSNLinking>
</MedlineJournalInfo>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>World J Clin Oncol. 2014 Aug 10;5(3):241-7</RefSource>
<PMID Version="1">25114841</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphology. 2009 Dec;42(4):161-75</RefSource>
<PMID Version="1">20218084</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncology (Williston Park). 1994 Sep;8(9):95-106; discussion 109-10</RefSource>
<PMID Version="1">7993730</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2014 Apr;133(4):905-13</RefSource>
<PMID Version="1">24352208</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Reconstr Microsurg. 2016 Jun;32(5):329-35</RefSource>
<PMID Version="1">26975564</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphat Res Biol. 2014 Dec;12(4):267-74</RefSource>
<PMID Version="1">25495382</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2011 Oct;128(4):941-7</RefSource>
<PMID Version="1">21681123</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphat Res Biol. 2005;3(4):208-17</RefSource>
<PMID Version="1">16379589</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Plast Surg. 2007 Oct;59(4):464-72</RefSource>
<PMID Version="1">17901744</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Med. 2012 Feb;125(2):134-40</RefSource>
<PMID Version="1">22269614</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Cancer. 1997 Feb;33(2):193-9</RefSource>
<PMID Version="1">9135487</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>World J Surg. 2004 Jun;28(6):609-13</RefSource>
<PMID Version="1">15366754</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Coll Surg. 2011 Oct;213(4):543-51</RefSource>
<PMID Version="1">21802319</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2011 May;127(5):1979-86</RefSource>
<PMID Version="1">21532424</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2016 Sep;138(3 Suppl):209S-18S</RefSource>
<PMID Version="1">27556764</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Nucl Med. 2003 Jan;44(1):43-57</RefSource>
<PMID Version="1">12515876</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vasc Med. 1998;3(2):145-56</RefSource>
<PMID Version="1">9796078</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2014 Mar;124(3):915-21</RefSource>
<PMID Version="1">24590276</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphat Res Biol. 2014 Dec;12(4):258-66</RefSource>
<PMID Version="1">25412401</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphology. 2007 Dec;40(4):172-6</RefSource>
<PMID Version="1">18365531</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2010 Dec;126(6):1853-63</RefSource>
<PMID Version="1">21124127</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Plast Surg. 1990 Sep;43(5):578-86</RefSource>
<PMID Version="1">2224354</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2013 Nov;132(5):1305-14</RefSource>
<PMID Version="1">24165613</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Vasc Surg. 2008 Mar;22(2):203-9</RefSource>
<PMID Version="1">18346573</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncology (Williston Park). 1997 Jan;11(1):99-109; discussion 110, 113-4</RefSource>
<PMID Version="1">9115856</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>CA Cancer J Clin. 2009 Jan-Feb;59(1):8-24</RefSource>
<PMID Version="1">19147865</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Phys Ther. 2006 Aug;86(8):1128-36</RefSource>
<PMID Version="1">16879046</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Surg. 2006 Mar;243(3):313-5</RefSource>
<PMID Version="1">16495693</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Oncol. 2006 Jun 20;24(18):2765-72</RefSource>
<PMID Version="1">16702582</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Oncol. 2013 May;14(6):500-15</RefSource>
<PMID Version="1">23540561</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Surg. 1927 Feb;85(2):185-93</RefSource>
<PMID Version="1">17865614</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immun Inflamm Dis. 2014 Nov;2(3):152-61</RefSource>
<PMID Version="1">25505549</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Cancer Res. 2012 Apr 15;18(8):2382-90</RefSource>
<PMID Version="1">22351697</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2015 Oct;136(4):883-93</RefSource>
<PMID Version="1">26086382</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2016 Jun;137(6):1673-80</RefSource>
<PMID Version="1">27219223</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pers Med. 2015 Aug 25;5(3):311-25</RefSource>
<PMID Version="1">26308061</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2004 Sep;10(9):974-81</RefSource>
<PMID Version="1">15322537</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphology. 2013 Jun;46(2):64-74</RefSource>
<PMID Version="1">24354105</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Plast Surg. 2012 Oct;39(4):385-98</RefSource>
<PMID Version="1">23036289</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Phys Med Rehabil. 1996 Mar;77(3 Suppl):S74-80</RefSource>
<PMID Version="1">8599548</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2014 Feb;133(2):192e-8e</RefSource>
<PMID Version="1">24469190</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 1990 Jan;85(1):64-74; discussion 75-6</RefSource>
<PMID Version="1">2293739</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Surg. 2015 May;261(5):1013-23</RefSource>
<PMID Version="1">24950271</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Oncol. 2007 Apr;18(4):639-46</RefSource>
<PMID Version="1">17018707</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dis Chest. 1962 Feb;41:220-4</RefSource>
<PMID Version="1">14450733</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Oncol. 2017 Feb;56(2):360-366</RefSource>
<PMID Version="1">28084150</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>World J Radiol. 2015 Nov 28;7(11):375-81</RefSource>
<PMID Version="1">26644823</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Phys Med Rehabil. 2011 May;92(5):756-764.e1</RefSource>
<PMID Version="1">21530723</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphat Res Biol. 2015 Jun;13(2):100-6</RefSource>
<PMID Version="1">25774851</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Reconstr Microsurg. 2016 Jan;32(1):56-65</RefSource>
<PMID Version="1">25893630</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Reconstr Microsurg. 2016 Jan;32(1):16-27</RefSource>
<PMID Version="1">25868153</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Microsurgery. 2014 Sep;34(6):421-4</RefSource>
<PMID Version="1">24677148</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 1977 Aug;60(2):197-211</RefSource>
<PMID Version="1">887661</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Oncol. 2007 Oct 1;25(28):4396-404</RefSource>
<PMID Version="1">17785708</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Surg Oncol. 2015 Sep;22(9):2919-24</RefSource>
<PMID Version="1">25623599</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Plast Surg. 2015 Aug;75(2):197-200</RefSource>
<PMID Version="1">24691335</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2015 Jul;136(1):114-8</RefSource>
<PMID Version="1">26111317</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Phys Med Rehabil. 2008 Jan;87(1):33-8</RefSource>
<PMID Version="1">17993983</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2015 Jan;135(1):277-85</RefSource>
<PMID Version="1">25285683</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Surg Forum. 1963;14:111-2</RefSource>
<PMID Version="1">14064471</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 1998 Oct;102(5):1486-98; discussion 1499-501</RefSource>
<PMID Version="1">9774002</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Breast. 2002 Feb;11(1):66-71</RefSource>
<PMID Version="1">14965648</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 1970 Jun;45(6):541-8</RefSource>
<PMID Version="1">4910556</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychooncology. 2013 Jul;22(7):1466-84</RefSource>
<PMID Version="1">23044512</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphat Res Biol. 2015 Jun;13(2):126-30</RefSource>
<PMID Version="1">26091408</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Invest. 2010 Jan;28(1):54-62</RefSource>
<PMID Version="1">19916749</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Microsurgery. 2017 Feb;37(2):177-178</RefSource>
<PMID Version="1">26892278</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2013 Jun;131(6):1286-98</RefSource>
<PMID Version="1">23714790</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Support Care Cancer. 2004 Jun;12(6):421-31</RefSource>
<PMID Version="1">15095073</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Surg Oncol. 2004 Mar 15;85(4):187-92</RefSource>
<PMID Version="1">14991874</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Microsurgery. 2002;22(2):74-80</RefSource>
<PMID Version="1">11921075</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Nurs. 2010 May;19(9-10):1270-4</RefSource>
<PMID Version="1">20345831</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Phys Ther. 1998 Dec;78(12):1302-11</RefSource>
<PMID Version="1">9859949</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Oncol. 2009;48(8):1102-10</RefSource>
<PMID Version="1">19863217</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lasers Med Sci. 2015 May;30(4):1377-85</RefSource>
<PMID Version="1">25820369</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):498-503</RefSource>
<PMID Version="1">23541809</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2013 Feb;131(2):283-90</RefSource>
<PMID Version="1">23357989</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Breast Cancer Res Treat. 2010 Apr;120(3):649-54</RefSource>
<PMID Version="1">20180016</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Lymphaticovenular bypass</Keyword>
<Keyword MajorTopicYN="N">Lymphedema</Keyword>
<Keyword MajorTopicYN="N">Lymphogram</Keyword>
<Keyword MajorTopicYN="N">Vascularized lymph node transfer</Keyword>
<Keyword MajorTopicYN="N">complete decongestive therapy</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2017</Year>
<Month>05</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2017</Year>
<Month>06</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>7</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>7</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>7</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">28679373</ArticleId>
<ArticleId IdType="doi">10.1186/s12885-017-3444-9</ArticleId>
<ArticleId IdType="pii">10.1186/s12885-017-3444-9</ArticleId>
<ArticleId IdType="pmc">PMC5497342</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000118 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000118 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:28679373
   |texte=   A comprehensive overview on the surgical management of secondary lymphedema of the upper and lower extremities related to prior oncologic therapies.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:28679373" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024